Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

DAPT (GSI-IX)

Catalog No.
A8200
γ-secretase inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$88.00
In stock
Evaluation Sample
$30.00
In stock
10mg
$83.00
In stock
50mg
$248.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

DAPT (CAS 208255-80-5) is an orally bioavailable γ-secretase inhibitor, functioning as a potent and selective blocker of γ-secretase activity in cellular systems and exhibiting inhibitory activity on Notch signaling pathways in diverse cell types. Additionally, it suppresses the proteolytic processing of amyloid precursor protein (APP) and Notch receptor substrates.

In cell-based assays, DAPT reduces the generation of amyloid-β peptides with an IC50 of 115 nM, as well as inhibits total γ-secretase activity with an IC50 of 200 nM, tested against various mammalian cell lines. It can also induce cellular differentiation, modulate downstream signaling cascades, and trigger autophagy and apoptosis depending on experimental conditions.

In basic and translational research applications, DAPT is widely used for the study of neurodegenerative diseases, such as Alzheimer’s disease, autoimmune disorders, lymphoproliferative conditions, and cancer. Furthermore, DAPT enables the dissection of Notch-related signaling mechanisms, providing a tool for evaluating the role of γ-secretase in cellular development, immune regulation, and tumorigenesis. Its application extends to investigations of cell fate determination and neuroprotection, supporting the development of novel therapeutic strategies targeting γ-secretase dependent pathways.

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt432.46
Cas No.208255-80-5
FormulaC23H26F2N2O4
SynonymsLY-374973
Solubility≥21.62 mg/mL in DMSO; insoluble in H2O; ≥16.36 mg/mL in EtOH with ultrasonic
Chemical Nametert-butyl (2S)-2-[[(2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoyl]amino]-2-phenylacetate
SDFDownload SDF
Canonical SMILESC[C@@H](C(N[C@H](C(OC(C)(C)C)=O)c1ccccc1)=O)NC(Cc1cc(F)cc(F)c1)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment [1]:

Cell lines

SHG -44 human glioma cell line

Preparation method

The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months.

Reaction Conditions

5d; 1.0 μM

Applications

Cell viability in each group was detected by MTT. Compared with those in group A (control), proliferation of SHG -44 cells in group B (0.5 μM), C (1μM), D (5 μM) and E (10 μM) were inhibited by DAPT. For group B and A, the results were significantly different (P0.05). It indicated that DAPT is a concentration-dependent inhibitor that may obviously inhibit SHG-44 cells proliferation. As concentration of DAPT higher than 1.0 μmol/L showed no more obvious disparities in cell inhibition, concentration of 1.0 μmol/L was our prioriy.

Animal experiment [2]:

Animal models

Male Balb/C mice

Dosage form

10 mg/kg/day; subcutaneously injected

Applications

CT26 colon adenocarcinoma cells (5 × 105 cells) in 500 μL of Phosphate buffer solution (PBS) were inoculated subcutaneously into the dorsum of all mice. Administration of DAPT significantly reduced serum sVEGFR1, while could not change serum VEGF concentration in control mice. Immunohistochemical study of the tumors showed that CD31 positive cells were reduced after DAPT administration (280.6 ± 81 vs. 386 ± 59.9 CD31 positive cells/mm2), although it was not statistically significant.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1] Liu X, Xu Q R, Xie W F, et al. DAPT suppresses the proliferation of human glioma cell line SHG-44[J]. Asian Pacific journal of tropical medicine, 2014, 7(7): 552-556.

[2] Kalantari E, Saeidi H, Kia N S, et al. Effect of DAPT, a gamma secretase inhibitor, on tumor angiogenesis in control mice[J]. Advanced biomedical research, 2013, 2.

Biological Activity

Description DAPT (GSI-IX) is a novel inhibitor of γ-secretase with IC50 of 20 nM in HEK 293 cells.
Targets          
IC50 20 nM          

Quality Control

Chemical structure

DAPT

Related Biological Data

DAPT
The result shows the level of Aβ40 and Aβ42 decreased as the DAPT concentration increased. Compared with Aβ42, the level of Aβ420 decreased more rapidly with increasing DAPT concentration.

Related Biological Data

DAPT

Related Biological Data

DAPT

Related Biological Data

DAPT

Related Biological Data

DAPT

Related Biological Data

DAPT

Related Biological Data

DAPT